# US 2013/0253359 A1 · Method for continuous and non-invasive determination of effective lung volume and cardiac output

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253359 A1
- Document ID: US20130253359A1
- Status: Published application
- Kind: A1
- Application number: 13/848,304
- Filed: 2013-03-21
- Published: 2013-09-26
- Earliest claimed: 2012-03-22
- Assignees: Maquet Critical Care AB
- Inventors: Par Emtell; Magnus Hallback
- Web page: https://patentgrep.com/patent/US20130253359A1

## CPC

- A61B 5/082: {Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath (A61B5/083, A61B5/091 take precedence)}
- A61B 5/029: Measuring blood output from the heart, e.g. minute volume
- A61B 5/0836: {Measuring rate of CO2 production}
- A61B 5/087: Measuring breath flow
- A61B 5/72: {Signal processing specially adapted for physiological signals or for diagnostic purposes}
- A61M 16/0051: {with alarm devices}
- A61M 16/026: {specially adapted for predicting, e.g. for determining an information representative of a flow limitation during a ventilation cycle by using a root square technique or a regression analysis}
- G16H 50/50: for simulation or modelling of medical disorders
- A61M 2016/0036: {in the breathing tube and used in both inspiratory and expiratory phase}
- A61M 2230/432: partial CO2 pressure (P-CO2)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

In a method for continuous and non-invasive determination of the effective lung volume, the cardiac output, and/or the carbon dioxide content of venous blood of a subject during a sequence of respiratory cycles, the inspiratory and expiratory flow, and the carbon dioxide content of at least the expiration gas are measured. In each respiratory cycle, a first parameter related to the subject's fraction of alveolar carbon dioxide, a second parameter related to the carbon dioxide content of the subject's arterial blood, and a third parameter related to the subject's carbon dioxide elimination are determined based on the measured inspiratory flow, expiratory flow and carbon dioxide content. The effective lung volume, the cardiac output, and/or the carbon dioxide content of venous blood of the subject is determined based on the correlation of the first, second and third parameters.

## Claims

### Claim 1

A non-invasive method for determining at least one physiological parameter related to the effective lung volume, the cardiac output, and/or the carbon dioxide content of venous blood of a subject, the method comprising the steps of, during a sequence of respiratory cycles:
measuring an inspiratory flow of inspiration gas inhaled by the subject and an expiratory flow of expiration gas exhaled by the subject, and
measuring the carbon dioxide content of at least the expiration gas,
determining, for each respiratory cycle in the sequence of respiratory cycles, a first parameter related to the fraction of alveolar carbon dioxide of the subject, a second parameter related to the carbon dioxide content of the arterial blood of the subject, and a third parameter related to carbon dioxide elimination of the subject, based on the measured inspiratory flow, expiratory flow and carbon dioxide content; and
determining said at least one physiological parameter based on the correlation of the first, second and third parameters in the sequence of respiratory cycles.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the step of determining said at least one physiological parameter comprises simultaneous determination of a physiological parameter related to the effective lung volume of the subject and a physiological parameter related to the cardiac output of the subject, based on said correlation.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the step of determining said at least one physiological parameter comprises simultaneous determination of a physiological parameter related to the effective lung volume of the subject, a physiological parameter related to the cardiac output of the subject, and a physiological parameter related the carbon dioxide content of venous blood of the subject, based on said correlation.

### Claim 4 (depends on 1)

The method according to claim 1, further comprising the steps of:
for each respiratory cycle in the sequence of respiratory cycles, inserting the determined values of the first, second and third parameters into a capnodynamic equation describing a relationship between parameters relating to effective lung volume, cardiac output, carbon dioxide content of venous blood, fraction of alveolar carbon dioxide, carbon dioxide content of arterial blood and carbon dioxide elimination of a subject, so as to form an overdetermined system of equations; and
determining the at least one physiological parameter by finding an approximate solution to said overdetermined system of equations.

### Claim 5 (depends on 4)

The method according to claim 4, wherein said capnodynamic equation is:
V·ΔFACO2=Δt·Q(CvCO2—CaCO2)—VTCO2,
where V is the effective lung volume during the respiratory cycle, ΔFACO2 is the change in volume fraction of alveolar carbon dioxide during the respiratory cycle, At is the duration in time of the respiratory cycle, Q is the effective pulmonary capillary blood flow during the respiratory cycle, CvCO2 is the carbon dioxide content of venous blood during the respiratory cycle, CaCO2 is the carbon dioxide content of arterial blood during the respiratory cycle, and VTCO2 is the tidal volume elimination of carbon dioxide during the respiratory cycle.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the at least one physiological parameter is determined on a breath-by-breath basis by, for each respiratory cycle, replacing the values of the first, second and third parameters obtained during the oldest respiratory cycle in the sequence of respiratory cycles with the values obtained during the most recent respiratory cycle.

### Claim 7 (depends on 1)

The method according to claim 1, wherein at least a physiological parameter related to the effective lung volume of the subject is determined, further comprising the steps of:
calculating the difference in volume of inspired and expired gas in each respiratory cycle from the measured inspiratory and expiratory flows; and
determining an updated value of a current effective lung volume of the subject based on the determined physiological parameter and said differences.

### Claim 8 (depends on 1)

The method according to claim 1, further comprising the steps of obtaining, prior to determination of the at least one physiological parameter, a priori information comprising at least one value of at least one of said physiological parameters using another method for determination of at least one of said physiological parameters, and using said a priori information in the determination of the at least one physiological parameter.

### Claim 9 (depends on 1)

The method according to claim 1, further comprising the steps of determining an error in the determination of the at least one physiological parameter based on the correlation of the first, second and third parameters in the sequence of respiratory cycles, and generating an alarm signal if the error indicates that the correlation is weak.

### Claim 10

A non-transitory, computer-readable data storage medium encoded with programming instructions for non-invasive determination of at least one physiological parameter related to the effective lung volume, the cardiac output, and/or the carbon dioxide content of venous blood of a subject, said storage medium being loaded into a processor of a device that also comprises at least one flow sensor for measuring an inspiratory flow of inspiration gas inhaled by the subject and an expiratory flow of expiration gas exhaled by the subject, at least one gas analyzer for measuring the carbon dioxide content of at least the expiration gas exhaled by the subject, said programming instructions causing said processor to:
measure an inspiratory flow of inspiration gas inhaled by the subject and an expiratory flow of expiration gas exhaled by the subject, and
measure the carbon dioxide content of at least the expiration gas,
determine, for each respiratory cycle in the sequence of respiratory cycles, a first parameter related to the fraction of alveolar carbon dioxide of the subject, a second parameter related to the carbon dioxide content of the arterial blood of the subject, and a third parameter related to carbon dioxide elimination of the subject, based on the measured inspiratory flow, expiratory flow and carbon dioxide content; and
determine said at least one physiological parameter based on the correlation of the first, second and third parameters in the sequence of respiratory cycles.

### Claim 11 (depends on 11)

A device for non-invasive determination of at least one physiological parameter related to the effective lung volume, the cardiac output, and/or the carbon dioxide content of venous blood of a subject, comprising:
at least one flow sensor that measures an inspiratory flow of inspiration gas inhaled by the subject and an expiratory flow of expiration gas exhaled by the subject, during a sequence of respiratory cycles;
at least one gas analyzer that measures the carbon dioxide content of at least the expiration gas; and
a control unit configured to determine, for each respiratory cycle in the sequence of respiratory cycles, a first parameter related to the fraction of alveolar carbon dioxide of the subject, a second parameter related to the carbon dioxide content of the arterial blood of the subject, and a third parameter related to carbon dioxide elimination of the subject, based on the measured inspiratory flow, expiratory flow and carbon dioxide content, and to determine said at least one physiological parameter based on the correlation of the first, second and third parameters in the sequence of respiratory cycles. The device according to claim 11, comprising components forming a breathing-assist apparatus, and wherein said control unit is configured to operate said breathing-assist apparatus to provide a ventilatory treatment to the subject.

### Claim 13 (depends on 12)

The device according to claim 12 wherein the control unit is configured to cause a change in the effective ventilation of the subject to cause the carbon dioxide content of the expiration gas exhaled by the subject to vary in a range of 0.5%-1% during said sequence of respiratory cycles.

### Claim 14 (depends on 13)

The device according to claim 13, wherein the control unit is configured to change the effective ventilation of the subject to deliver a ventilation pattern with alternating sequences of breaths of increased ventilation and breaths of decreased ventilation to the subject.
